Latest Westlake Ventures News
May 29, 2018
Send to A group of VCs including Yashang Capital and Westlake Ventures have backed a $20 million Series A funding round for Singaporean biotech developer Lion TCR. According to a statement, the capital will be used primarily to advance clinical trials for company’s lead development product, a cancer treatment known as LioCyx, in major hospitals in China and Singapore.... To continue reading...
Westlake Ventures Team
1 Team Member
Westlake Ventures has 1 team member, including current Managing Director, Hong Xue.